Literature DB >> 20498621

Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.

Raffaele Izzo1, Giovanni de Simone, Renata Giudice, Marcello Chinali, Valentina Trimarco, Nicola De Luca, Bruno Trimarco.   

Abstract

BACKGROUND: Nutraceuticals (NUTs) are forms of compounds with biological activity and are used to improve health in dosage largely exceeding those obtainable in food.
OBJECTIVES: To investigate whether addition of NUTs to lifestyle management including diet counseling improves lipid profile and reduces cardiovascular risk and prevalence of metabolic syndrome (MetS).
METHODS: One thousand, three hundred and eighty, 18-80-year-old nondiabetic participants with dyslipidemia, with or without MetS not requiring pharmacological therapy were assigned to diet; after 2 weeks, 690 patients were also given NUT combination over other 8 weeks. Fasting plasma glucose and lipid compounds were measured by standard methods. Waist circumference, systolic and diastolic blood pressure (BP) were measured at each visit. MetS was defined according to ATPIII guidelines. Ten-year risk of coronary heart disease was calculated using the Framingham Risk Score (FRS).
RESULTS: At baseline, NUT patients were older and more dyslipidemic than placebo, with no difference in other cardiovascular risk factors and prevalence of MetS. After 8 weeks, high-density lipoprotein (HDL) cholesterol was increased and diastolic BP, waist girth, triglycerides, total and non-HDL cholesterol were significantly reduced in NUT than in the placebo group, whereas systolic BP and fasting glucose did not change. Prevalence of MetS was also significantly lower in the NUT (36.1%) than in placebo (48.1%, P < 0.05) and reduction in the FRS greater (73.3 vs. 52%, respectively; P < 0.0001).
CONCLUSION: In a large clinical sample of patients with moderate cardiovascular risk, combination of NUT with dietary counseling reduces central obesity, improves lipid profile, diastolic BP and FRS, and decreases prevalence of MetS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498621     DOI: 10.1097/HJH.0b013e3283395208

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  22 in total

Review 1.  Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.

Authors:  Roberto Volpe; Gianluca Sotis
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-01

2.  The Age of Nutraceuticals: Exploring New Therapeutic Targets.

Authors:  Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-11-04

3.  Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.

Authors:  Francesco Rozza; Valentina Trimarco; Raffaele Izzo; Davide Grassi; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-09-19

4.  Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension.

Authors:  Valentina Trimarco; Claudia Sara Cimmino; Mario Santoro; Gianpiero Pagnano; Maria Virginia Manzi; Anna Piglia; Caterina Anna Giudice; Nicola De Luca; Raffaele Izzo
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-09-01

Review 5.  The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review.

Authors:  Mohammad Amin Atazadegan; Mohammad Bagherniya; Omid Fakheran; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly.

Authors:  Linlin Wang; Hongtian Li; Yuan Zhou; Lei Jin; Jianmeng Liu
Journal:  Eur J Nutr       Date:  2014-06-11       Impact factor: 5.614

Review 7.  Polyphenols: a Promising Nutritional Approach to Prevent or Reduce the Progression of Prehypertension.

Authors:  Sergio Davinelli; Giovanni Scapagnini
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-26

8.  The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.

Authors:  Alberto Mazza; Laura Schiavon; Gianluca Rigatelli; Gioia Torin; Salvatore Lenti
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-07-27

9.  Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet.

Authors:  Bruno Trimarco; Claudio Benvenuti; Francesco Rozza; Claudia Sara Cimmino; Renata Giudice; Salvatore Crispo
Journal:  Med J Nutrition Metab       Date:  2011-02-03

10.  Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.

Authors:  Valentina Trimarco; Raffaele Izzo; Eugenio Stabile; Francesco Rozza; Mario Santoro; Maria Virginia Manzi; Federica Serino; Gabriele Giacomo Schiattarella; Giovanni Esposito; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.